Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 31 | Movymia | Authorised | teriparatide | Osteoporosis | STADA Arzneimittel AG | 19-02-2018 |
| 32 | Steqeyma | Authorised | ustekinumab | Psoriasis;Arthritis, Psoriatic;Crohn Disease | Celltrion Healthcare Hungary Kft. | 18-06-2024 |
| 33 | Qoyvolma | Authorised | ustekinumab | Psoriasis;Arthritis, Psoriatic;Colitis, Ulcerative;Crohn Disease | Celltrion Healthcare Hungary Kft. | 28-03-2025 |
| 34 | Enwylma | Authorised | Neoplasms, Bone Tissue;Giant Cell Tumor of Bone | Zentiva k.s. | 25-04-2025 | |
| 35 | Pavblu | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Retinal Vein Occlusion;Choroidal Neovascularization;Diabetes Complications | Amgen Technology (Ireland) UC | 31-01-2025 |
| 36 | Mynzepli | Authorised | aflibercept | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | Advanz Pharma Limited | 20-06-2025 |
| 37 | Ziextenzo | Authorised | pegfilgrastim | Sandoz GmbH | 21-09-2018 | |
| 38 | Vevzuo | Authorised | denosumab | Neoplasms, Bone Tissue;Giant Cell Tumor of Bone | Biosimilar Collaborations Ireland Limited | 25-04-2025 |
| 39 | Zirabev | Authorised | bevacizumab | Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | Pfizer Europe MA EEIG | 11-12-2018 |
| 40 | Bemfola | Authorised | follitropin alfa | Anovulation | Gedeon Richter Plc. | 15-05-2018 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.